Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Pathology

Adenoma Subtypes and Biology

At a Glance

Breast adenomas are benign tumors, but the subtype matters. Tubular adenomas may be monitored, while lactating adenomas often shrink after breastfeeding. Pleomorphic, nipple, syringomatous, and other complex types may need complete removal because they can recur or resemble cancer.

While an ordinary breast adenoma is benign, “adenoma” is actually a broad category. The biology—the way the cells are built and behave—varies significantly between different subtypes. Understanding these differences is more than just academic; the specific subtype of your adenoma often determines whether your doctor recommends simple observation or surgical removal.

The Core Difference: Epithelial vs. Fibroepithelial

The most important biological distinction is between a “pure” adenoma and the more common fibroadenoma.

  • Pure Adenoma (Epithelial): These tumors are made almost entirely of glandular or epithelial cells—the cells that form the ducts and milk-producing glands of the breast [1][2]. Under a microscope, they show very little stroma (the connective “scaffolding” tissue) [3].
  • Fibroadenoma (Fibroepithelial): These are “biphasic,” meaning they have two parts: the glandular cells and a significant amount of connective tissue [2].

Biologically, these two conditions can have different microscopic and genetic signatures, but both are generally benign entities that often present similarly on imaging.

Common Benign Subtypes

Tubular Adenoma

A tubular adenoma is the most common “true” adenoma found in women who are not pregnant. Biologically, it is made of thousands of tiny, tightly packed “tubules” or tube-like structures [4].

  • Appearance: On a mammogram or ultrasound, they look almost identical to fibroadenomas [3].
  • Behavior: They are benign epithelial tumors that generally do not grow very large. They are often found in premenopausal women and do not require removal unless they cause discomfort or the diagnosis is uncertain [4][3].

Lactating Adenoma

A lactating adenoma is a subtype specifically linked to the hormonal environment of pregnancy and breastfeeding [5].

  • Biology: These tumors show “secretory” changes, meaning the cells look like they are actively preparing to produce milk [5].
  • Behavior: Because they are highly sensitive to hormones, they can enlarge rapidly during the third trimester [4]. They usually shrink on their own after breastfeeding ends, but they require careful monitoring to ensure they aren’t hiding a different type of growth [5].

Rare and Complex Subtypes

Some adenomas have more complex biology. These rare variants are important because they can mimic cancer on imaging or limited biopsies, and their management often requires complete excision.

Pleomorphic Adenoma

A pleomorphic adenoma is rare and biologically unique because it contains a “myxochondroid matrix”—a tissue that can look a bit like cartilage under the microscope [6].

  • Why it matters: These tumors can mimic malignancy. If they are not fully removed, they have a risk of growing back locally (recurrence) [7]. Complete surgical removal is usually recommended.

Syringomatous and Nipple Adenomas

These occur in or near the nipple and are made of small ducts and tubules [8][9].

  • Nipple Adenoma: These are benign growths of the nipple’s milk ducts. Excision is often curative, but they can recur if incompletely excised [9].
  • Syringomatous Adenoma: This type is benign but locally “infiltrative,” meaning it grows unevenly into surrounding tissue rather than as a smooth ball [8]. Because this growth pattern looks very similar to certain low-grade breast cancers (tubular carcinoma), doctors generally recommend complete surgical excision to be absolutely certain of the diagnosis and prevent it from returning [10][11].

Adenomyoepithelioma

This is a complex tumor involving both the inner lining and the outer muscle-like layer of the breast ducts. While usually benign, they can occasionally behave aggressively or be indeterminate on a core biopsy. They often prompt a wider surgical excision to ensure all margins are clear [12].

Knowing your specific subtype allows your care team to tailor your follow-up, ensuring that “well-behaved” tubular adenomas are monitored, while more complex or rare variants are completely removed for your long-term peace of mind.

Common questions in this guide

How is a pure breast adenoma different from a fibroadenoma?
A pure breast adenoma is made mostly of glandular or epithelial cells. A fibroadenoma contains both glandular cells and a larger amount of connective tissue. Both are generally benign and can look similar on breast imaging.
Does a tubular adenoma always need to be removed?
No. A tubular adenoma may be monitored when the biopsy diagnosis is clear, the imaging findings fit, and it is not causing discomfort. Removal may be considered if the diagnosis is uncertain or the lump is bothersome.
What happens to a lactating adenoma after pregnancy or breastfeeding?
A lactating adenoma is influenced by the hormones of pregnancy and breastfeeding and may grow quickly late in pregnancy. It often shrinks after breastfeeding ends, but follow-up is important to make sure another type of growth is not present.
Why might a pleomorphic or syringomatous adenoma need complete removal?
Pleomorphic adenomas can grow back if they are not fully removed. Syringomatous adenomas can extend unevenly into nearby tissue and may resemble a low-grade breast cancer, so complete excision helps confirm the diagnosis and reduce the chance of recurrence.
What does it mean if the margins of an adenoma are not clear?
Unclear margins mean that the removed tissue may not include all of the adenoma. Depending on the subtype and the pathology findings, a surgeon may recommend a wider or complete excision. Your pathologist and surgeon can explain what the margin result means in your case.
Can a breast adenoma be mistaken for cancer?
Yes. Some rare or complex adenoma subtypes can look like cancer on imaging or in a small biopsy. A specialist breast pathologist may review the tissue and compare the pathology with the imaging before the treatment plan is finalized.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on breast adenoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my biopsy diagnosis unequivocal, and does the imaging adequately explain the pathology?
  2. 2.If my diagnosis is a pleomorphic adenoma, were the margins of the biopsy clear, or do I need a wider excision to prevent recurrence?
  3. 3.For my nipple or syringomatous adenoma, how did the pathologist distinguish it from similar-looking conditions like tubular carcinoma?
  4. 4.Has my pathology been reviewed by a specialist breast pathologist?
  5. 5.Since my adenoma is purely epithelial, does that change the way we monitor it compared to a more common fibroadenoma?

References

References (12)
  1. 1

    [Pathology of the nipple-areola complex : Part II. Tumors, tumor-like lesions, and supernumerary breast lesions].

    Gutjahr E, Streng A, Aulmann S, et al.

    Der Pathologe 2020; (41(5)):515-522 doi:10.1007/s00292-020-00790-z.

    PMID: 32458047
  2. 2

    Advanced, Recurrent Malignant Phyllodes Tumor With Malignant Heterologous Osteoid Differentiation Coexisting With Fibroadenoma in a 17-Year-Old Female Nigerian: A Case Report.

    Dallang BC, Ezike KN, Aghahowa ME, et al.

    Cureus 2025; (17(4)):e82448 doi:10.7759/cureus.82448.

    PMID: 40385760
  3. 3

    Giant tubular adenoma of the accessory breast in the anterior chest wall occurred in a pregnant woman.

    Huang Y, Zhang H, Zhou Q, et al.

    Diagnostic pathology 2015; (10()):60 doi:10.1186/s13000-015-0286-0.

    PMID: 26040320
  4. 4

    Genetic and immunohistochemical studies identify recurrent ACTB mutations and PTEN alterations in tubular adenomas of the breast.

    Ingyin H, Solomon JP, Li Y, et al.

    Histopathology 2026; (88(6)):1229-1235 doi:10.1111/his.70082.

    PMID: 41456879
  5. 5

    Ultrasound Findings of Breast Adenomas.

    Macedo M, Bassaganyas C, Ganau S, et al.

    Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2020; (39(11)):2173-2180 doi:10.1002/jum.15328.

    PMID: 32385901
  6. 6

    Pleomorphic adenoma of breast: a radiological and pathological study of a common tumor in an uncommon location.

    Ginter PS, Scognamiglio T, Tauchi-Nishi P, et al.

    Case reports in pathology 2015; (2015()):172750 doi:10.1155/2015/172750.

    PMID: 25830053
  7. 7

    Pleomorphic adenoma of the lacrimal gland: A review with updates on malignant transformation and molecular genetics.

    Harrison W, Pittman P, Cummings T

    Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2018; (32(1)):13-16 doi:10.1016/j.sjopt.2018.02.014.

    PMID: 29755265
  8. 8

    Syringomatous Tumor Originating From an Axillary Supernumerary Mammary Tissue: First Report of an Axillary Tumor Case.

    Tominaga M, Horiguchi SI, Nishizawa A, et al.

    The American Journal of dermatopathology 2026; (48(7)):551-555 doi:10.1097/DAD.0000000000003259.

    PMID: 41774141
  9. 9

    Nipple Adenoma: Clinicopathologic Characterization of 50 Cases.

    Weigelt MA, Sciallis AP, McIntire PJ, et al.

    The American journal of surgical pathology 2023; (47(8)):926-932 doi:10.1097/PAS.0000000000002063.

    PMID: 37272622
  10. 10

    Syringomatous Adenoma of the Nipple with Associated Invasive Carcinoma: A Case Report.

    Pratt D, Sunassee A

    South Dakota medicine : the journal of the South Dakota State Medical Association 2022; (75(7)):302-303.

    PMID: 36542569
  11. 11

    Syringomatous adenoma of the nipple: A case series and systematic review.

    Park SK, Samat SH, Whitelock CM, Fortes T

    Clinical case reports 2023; (11(6)):e7521 doi:10.1002/ccr3.7521.

    PMID: 37346881
  12. 12

    Diagnostic Challenges and Pitfalls of Mammary Pleomorphic Adenoma Illustrated by a Case Report.

    Joyon N, Mathieu MC, Rouleau E, et al.

    International journal of surgical pathology 2023; (31(4)):472-477 doi:10.1177/10668969221102552.

    PMID: 35635223

This page explains breast adenoma subtypes for informational purposes only and does not constitute medical advice. Your breast pathologist and surgeon can interpret your biopsy and advise whether monitoring or excision is appropriate for you.